Bipolar disorder.
Geddes
John
J
Department of Psychiatry University of Oxford, Oxford, UK.
D000928:Antidepressive Agents / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002746:Chlorpromazine / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D006801:Humans; D016651:Lithium Carbonate / Q000627:therapeutic use; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D000928:Antidepressive Agents; D018692:Antimanic Agents; D010879:Piperazines; D013844:Thiazoles; D001569:Benzodiazepines; D016651:Lithium Carbonate; D014635:Valproic Acid; C092292:ziprasidone; D000077152:Olanzapine; D002746:Chlorpromazine